[1]
S. Molica, P. Sportoletti, N. . Di Renzo, P. Musto, F. Pane, and F. Di Raimondo, “Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy”., Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021042, Jun. 2021.